Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Cell Death Discovery
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. cell death discovery
  3. articles
  4. article
Histone lactylation modification promotes docetaxel resistance and tumor progression through CNN1-Mediated autophagy and cell cycle arrest in Castration-resistant prostate cancer
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 13 May 2026

Histone lactylation modification promotes docetaxel resistance and tumor progression through CNN1-Mediated autophagy and cell cycle arrest in Castration-resistant prostate cancer

  • Ruijie Mao1,2,
  • Xu Chen3,
  • Xing Fu3,
  • Dingyuan Yang4,
  • Wenqiang Chen5 &
  • …
  • Jun Li  ORCID: orcid.org/0000-0002-2743-14202,3 

Cell Death Discovery (2026) Cite this article

  • 657 Accesses

  • 5 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Autophagy
  • Post-translational modifications
  • Prostate cancer

Abstract

Castration-resistant prostate cancer (CRPC) constitutes an advanced stage of prostate cancer (PCa) that emerges following conventional androgen deprivation therapy (ADT). Docetaxel (DTX), a standard chemotherapeutic agent, is integral to the therapeutic regimen for CRPC. However, the development of resistance to DTX has significantly impeded its clinical efficacy. Histone lactylation and elevated lactate production are emerging as critical factors in cancer biology, yet their roles in CRPC and DTX resistance remain poorly understood. This study investigated the relationship between histone lactylation, lactate production, and DTX resistance in CRPC. Clinical analysis revealed significantly increased pan-lactylated protein (Pan Kla) expression in CRPC tissues compared to PCa, accompanied by elevated lactate production and lactate dehydrogenase (LDH) activity. Higher Pan Kla expression was linked to poor prognosis in CRPC. DTX-resistant CRPC (CRPC-R) samples exhibited significantly elevated Pan Kla and histone lactylation modifications, especially at H3K18la and H4K12la sites. Inhibition of lactate production using 2-deoxyglucose (2-DG) and oxamate reduced DTX resistance, suppressed cell migration, induced G0/G1 phase arrest, and promoted autophagy. Moreover, CNN1 was identified as a potential downstream target of histone lactylation modifications in CRPC. Elevated CNN1 expression correlated with increased lactylation and DTX resistance, whereas its inhibition reversed the effects of lactate inhibition on cell cycle progression and autophagy. In vivo, CNN1 overexpression counteracted the tumor-suppressive effects of lactate inhibition, restoring tumor growth and autophagy levels. These findings suggested that histone lactylation and lactate metabolism, mediated by CNN1, play a crucial role in DTX resistance and tumor progression in CRPC, offering potential therapeutic targets for overcoming chemoresistance in CRPC.

Similar content being viewed by others

Histone lactylation-driven feedback loop modulates pyrimidine metabolism to promote oral carcinogenesis

Article Open access 19 March 2026

Protein lactylation in cancer: mechanisms and potential therapeutic implications

Article Open access 24 March 2025

Lactic acid promotes metastasis of papillary thyroid carcinoma by enhancing CPT1A lactylation

Article Open access 27 April 2026

Acknowledgements

We appreciate the assistance of our laboratory colleagues in this research.

Funding

This work was financially supported by Sichuan Science and Technology Program (22NSFC2799).

Author information

Authors and Affiliations

  1. Department of Urology, North Sichuan Medical College, Nanchong, 637000, China

    Ruijie Mao

  2. Department of Urology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China

    Ruijie Mao & Jun Li

  3. Department of Urology, Chengdu Xinjin District People’s Hospital, Chengdu, 611430, China

    Xu Chen, Xing Fu & Jun Li

  4. Department of Urology, Chengdu No.2 People’s Hospital, Chengdu, 610021, China

    Dingyuan Yang

  5. Department of Urology, Yibin No.2 People’s Hospital, Yibin, 644000, China

    Wenqiang Chen

Authors
  1. Ruijie Mao
    View author publications

    Search author on:PubMed Google Scholar

  2. Xu Chen
    View author publications

    Search author on:PubMed Google Scholar

  3. Xing Fu
    View author publications

    Search author on:PubMed Google Scholar

  4. Dingyuan Yang
    View author publications

    Search author on:PubMed Google Scholar

  5. Wenqiang Chen
    View author publications

    Search author on:PubMed Google Scholar

  6. Jun Li
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Jun Li.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

This study was approved by the Ethics Committee of Sichuan Provincial People’s Hospital (Approval No.2023-580). All methods were performed in accordance with the relevant guidelines and regulations.

Informed consent for study participation

All participants gave a written informed consent for participation in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplemental Material (download DOCX )

original images of Western blots (download PDF )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mao, R., Chen, X., Fu, X. et al. Histone lactylation modification promotes docetaxel resistance and tumor progression through CNN1-Mediated autophagy and cell cycle arrest in Castration-resistant prostate cancer. Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03141-8

Download citation

  • Received: 14 December 2025

  • Revised: 30 March 2026

  • Accepted: 27 April 2026

  • Published: 13 May 2026

  • DOI: https://doi.org/10.1038/s41420-026-03141-8

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Journal Information
  • About the Editors
  • Contact
  • About the Partner
  • Upcoming Conferences
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Cell Death Discovery (Cell Death Discov.)

ISSN 2058-7716 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited